AustralianSuper Pty Ltd Takes $15.74 Million Position in Aveanna Healthcare Holdings Inc. $AVAH

AustralianSuper Pty Ltd purchased a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,774,837 shares of the company’s stock, valued at approximately $15,743,000.

A number of other institutional investors have also recently bought and sold shares of the business. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare during the second quarter worth approximately $43,000. MQS Management LLC acquired a new stake in Aveanna Healthcare during the second quarter worth approximately $59,000. Belvedere Trading LLC bought a new position in Aveanna Healthcare during the 2nd quarter worth $62,000. State of Alaska Department of Revenue acquired a new position in Aveanna Healthcare in the 3rd quarter valued at $106,000. Finally, Oxford Asset Management LLP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $64,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Trading Up 1.1%

Shares of Aveanna Healthcare stock opened at $8.34 on Friday. The firm has a market capitalization of $1.74 billion, a PE ratio of 23.17 and a beta of 2.06. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm’s 50 day moving average is $8.86 and its 200 day moving average is $8.03. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, November 6th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.08. The firm had revenue of $621.94 million for the quarter, compared to analyst estimates of $578.57 million. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In other news, CAO Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $93,901.70. Following the sale, the chief accounting officer directly owned 251,676 shares of the company’s stock, valued at approximately $1,975,656.60. This trade represents a 4.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Matthew Buckhalter sold 18,340 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $143,969.00. Following the completion of the transaction, the chief financial officer directly owned 436,980 shares of the company’s stock, valued at $3,430,293. This represents a 4.03% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 259,638 shares of company stock worth $2,109,595 over the last three months. 7.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

AVAH has been the topic of a number of recent analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Truist Financial increased their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Raymond James Financial restated an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Jefferies Financial Group upped their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Finally, Barclays lifted their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.